title: Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients.
authors.affiliation: Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Université Toulouse III Paul-Sabatier, ERL 5294 CNRS, Toulouse, France.|Laboratoire d'Excellence 'TOUCAN', Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Institut Carnot Lymphome CALYM, Pierre-Benite, France.
authors.forename: F
authors.initials: F
authors.lastname: Boissard
authors.affiliation: Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Université Toulouse III Paul-Sabatier, ERL 5294 CNRS, Toulouse, France.|Laboratoire d'Excellence 'TOUCAN', Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Institut Carnot Lymphome CALYM, Pierre-Benite, France.
authors.forename: J-J
authors.initials: JJ
authors.lastname: Fournié
authors.affiliation: Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Université Toulouse III Paul-Sabatier, ERL 5294 CNRS, Toulouse, France.|Laboratoire d'Excellence 'TOUCAN', Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Institut Carnot Lymphome CALYM, Pierre-Benite, France.
authors.forename: A
authors.initials: A
authors.lastname: Quillet-Mary
authors.affiliation: Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Université Toulouse III Paul-Sabatier, ERL 5294 CNRS, Toulouse, France.|Laboratoire d'Excellence 'TOUCAN', Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Institut Carnot Lymphome CALYM, Pierre-Benite, France.|Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, France.
authors.forename: L
authors.initials: L
authors.lastname: Ysebaert
authors.affiliation: Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Université Toulouse III Paul-Sabatier, ERL 5294 CNRS, Toulouse, France.|Laboratoire d'Excellence 'TOUCAN', Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Institut Carnot Lymphome CALYM, Pierre-Benite, France.
authors.forename: M
authors.initials: M
authors.lastname: Poupot
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D019008:Drug Resistance, Neoplasm / Q000276:immunology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology / Q000473:pathology*; D009000:Monocytes / Q000473:pathology; D010880:Piperidines; D011720:Pyrazoles / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D059016:Tumor Microenvironment / Q000276:immunology*
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine